Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  > SCHEME PROFILE
SCHEME PROFILE      
AMC : Category : Scheme :
Tata India Pharma & Healthcare Fund-Reg(G)
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesSUN PHARMACEUTICAL INDUSTRIES LTD.9.6561723130125.6077
Domestic EquitiesMAX HEALTHCARE INSTITUTE LTD.6.782680799688.2291
Domestic EquitiesDIVI LABORATORIES LTD.5.941412060077.2865
Domestic EquitiesABBOTT INDIA LTD.5.59902745372.8328
Domestic EquitiesHEALTHCARE GLOBAL ENTERPRISES LTD.5.0435113968765.6061
Domestic EquitiesAPOLLO HOSPITALS ENTERPRISE LTD.4.99988315365.0381
Domestic EquitiesCIPLA LTD.4.548143882859.1628
Domestic EquitiesRAINBOW CHILDRENS MEDICARE LTD.3.831641895049.8425
Domestic EquitiesMANKIND PHARMA LTD3.403519698144.2734
Domestic EquitiesBAYER CROPSCIENCE LTD.3.33429282443.3711
Domestic EquitiesFORTIS HEALTHCARE LTD.3.271445144442.5554
Domestic EquitiesSAI LIFE SCIENCES LTD3.254042402442.3282
Domestic EquitiesJ.B.CHEMICALS & PHARMACEUTICALS LTD.3.206620312441.7115
Domestic EquitiesMETROPOLIS HEALTHCARE LTD.3.127221367640.6796
Domestic EquitiesLUPIN LTD.3.083317423940.1081
Domestic EquitiesDR REDDYS LABORATORIES LTD.3.044330786339.6004
Domestic EquitiesDR. LAL PATH LABS LTD.2.712325203035.2817
Domestic EquitiesKRISHNA INSTITUTE OF MEDICAL SCIENCES LTD.2.641646121634.3629
Domestic EquitiesSYNGENE INTERNATIONAL LTD.2.394973787931.1533
Domestic EquitiesALKEM LABORATORIES LTD.2.15324966728.0097
Domestic EquitiesAJANTA PHARMA LTD.2.05828942626.7733
Domestic EquitiesNEULAND LABORATORIES LTD.1.99792026425.9886
Domestic EquitiesSANOFI INDIA LTD.1.98956526825.8794
Domestic EquitiesGLAXOSMITHKLINE PHARMACEUTICALS LTD.1.82339222723.7171
Domestic EquitiesFDC LTD.1.817266280523.6389
Domestic EquitiesVIJAYA DIAGNOSTIC CENTRE LTD.1.550820082320.1727
Domestic EquitiesGLOBAL HEALTH LTD.1.504717187919.5736
Domestic EquitiesTORRENT PHARMACEUTICALS LTD.1.06893208613.9038
Domestic EquitiesCORONA REMEDIES LTD0.99438149012.9341
Domestic EquitiesHIKAL LTD.0.59553938217.7457
Domestic EquitiesJUBILANT PHARMOVA LTD0.0715107350.9300
Domestic EquitiesDR. AGARWALS HEALTH CARE LTD.0.0699201290.9092
Domestic EquitiesLAXMI DENTAL LIMITED0.0213143570.2765
Domestic EquitiesIPCA LABORATORIES LTD.0.00292490.0381
Total 97.5945 1269.5219
Cash & Cash Equivalents and Net AssetsCASH / NET CURRENT ASSET2.2051 28.6841
Cash & Cash Equivalents and Net AssetsA) REPO0.2004 2.6066
Total 2.4055 31.2907
 
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Smart ODR Portal | Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst | UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.